New Clinical Abstract Available Online During National Kidney Foundation Spring Clinical Meeting (NKF) EDEN PRAIRIE, Minn., April 08, 2021 (GLOBE NEWSWIRE) — Bringing transportable care directly to patients who are too critically-ill to be moved could be the difference between life and death. New evidence demonstrates that ultrafiltration therapy (aquapheresis) […]
Other News
EP Lab Digest Features Physician Experience with BioSig’s Cardiac Signal Acquisition Technology
Westport, CT, April 08, 2021 (GLOBE NEWSWIRE) — Leading industry publication highlights the rising importance of intracardiac signals in complex cardiac ablations that treat irregular heart rhythm disorders High-quality intracardiac signals are deemed essential to determine ablation endpoints PURE EP™’s signals are described as ‘indispensable’ by the physician user BioSig […]
Cardiovascular Systems, Inc. Announces Investment and Acquisition Option Agreement With Telehealth Company, CarePICS, LLC
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that it has completed a minority investment and entered into an acquisition option agreement with CarePICS, LLC (CarePICS®), a telehealth company offering a virtual care platform designed to improve the outcomes of patients suffering from peripheral artery disease (PAD), […]
Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today announced that Ronald R. Blanck, D.O., Gregory Pepin and Chris A. Rallis have voluntarily agreed to step down from the […]
AtriCure Names B. Kristine Johnson Board Chair
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that B. Kristine (Kris) Johnson has been named Board Chair. In addition, the Company announced that Scott Drake and Mark Lanning will not stand for re-election at […]
RapidAI Named Exclusive Advanced Neuroimaging Partner for the WSO and SIECV Stroke Center Certification Program in Latin America
RapidAI Partners with the World Stroke Organization and Sociedad Iberoamericana de Enfermedad Cerebrovascular to Expand the Availability of AI-Powered Stroke Imaging Throughout Latin America MENLO PARK, Calif.–(BUSINESS WIRE)–RapidAI, the leader in advanced cerebrovascular imaging, today announced it has partnered with the World Stroke Organization (WSO) and Sociedad Iberoamericana de Enfermedad […]
Oxford Endovascular Ltd raises $10m to develop an origami engineered medical device to prevent brain haemorrhage
Funding will support the company to achieve first in-human data Oxford, UK, 8th April 2021 – Oxford Endovascular, a pioneering British MedTech company and spin-out from Oxford University, is developing a treatment for brain aneurysms, that will overcome challenges with existing medical devices. It has just raised $10m in […]
Medcura publishes successful results from clinical study
Demonstrating rapid hemorrhage control and improved patient outcomes RIVERDALE, Md., April 7, 2021 /PRNewswire/ — Medcura, Inc., a commercial-stage medical device company, announced today that it has published the results of a peer-reviewed clinical study at the University of Chicago in this month’s Cardiovascular Catheterization and Interventions (CCI)https://www.medcurainc.com/publications/16998937.pdf. This first-in-human study evaluated the clinical use of […]
TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System
Panel votes 12 to 5 that benefits of OCS Heart System outweigh risks ANDOVER, Mass., April 6, 2021 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that after the review of TransMedics’ clinical […]
Enrollment Completed in Clinical Trial Evaluating Effect of Exclusive Human Milk Diet Including a Specialty Fortifier in Term Infants Born With Single Ventricle Physiology
DUARTE, Calif., April 7, 2021 /PRNewswire/ — Prolacta Bioscience, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today that enrollment is now complete in a clinical trial evaluating the effect of an exclusive human milk diet (EHMD),1 including a specialty fortifier, for term infants who have undergone a corrective procedure for […]



